1. Home
  2. VCEL vs NBTB Comparison

VCEL vs NBTB Comparison

Compare VCEL & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • NBTB
  • Stock Information
  • Founded
  • VCEL 1989
  • NBTB 1856
  • Country
  • VCEL United States
  • NBTB United States
  • Employees
  • VCEL N/A
  • NBTB N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • NBTB Major Banks
  • Sector
  • VCEL Health Care
  • NBTB Finance
  • Exchange
  • VCEL Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • VCEL 2.1B
  • NBTB 2.0B
  • IPO Year
  • VCEL 1997
  • NBTB N/A
  • Fundamental
  • Price
  • VCEL $41.49
  • NBTB $44.38
  • Analyst Decision
  • VCEL Strong Buy
  • NBTB Buy
  • Analyst Count
  • VCEL 8
  • NBTB 3
  • Target Price
  • VCEL $61.75
  • NBTB $52.33
  • AVG Volume (30 Days)
  • VCEL 547.9K
  • NBTB 403.0K
  • Earning Date
  • VCEL 05-08-2025
  • NBTB 04-24-2025
  • Dividend Yield
  • VCEL N/A
  • NBTB 3.06%
  • EPS Growth
  • VCEL 521.85
  • NBTB 17.05
  • EPS
  • VCEL 0.05
  • NBTB 3.03
  • Revenue
  • VCEL $238,541,000.00
  • NBTB $569,473,000.00
  • Revenue This Year
  • VCEL $23.23
  • NBTB $26.01
  • Revenue Next Year
  • VCEL $24.41
  • NBTB $12.35
  • P/E Ratio
  • VCEL $698.68
  • NBTB $14.69
  • Revenue Growth
  • VCEL 14.80
  • NBTB 13.26
  • 52 Week Low
  • VCEL $37.39
  • NBTB $34.47
  • 52 Week High
  • VCEL $63.00
  • NBTB $52.44
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 49.55
  • NBTB 62.41
  • Support Level
  • VCEL $37.48
  • NBTB $41.71
  • Resistance Level
  • VCEL $44.41
  • NBTB $45.56
  • Average True Range (ATR)
  • VCEL 1.86
  • NBTB 1.01
  • MACD
  • VCEL 0.61
  • NBTB 0.29
  • Stochastic Oscillator
  • VCEL 58.40
  • NBTB 70.86

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

Share on Social Networks: